Global Continuous Glucose Monitoring Devices Market Growth (Status and Outlook) 2024-2030
According to our LPI (LP Information) latest study, the global Continuous Glucose Monitoring Devices market size was valued at US$ 4511.7 million in 2023. With growing demand in downstream market, the Continuous Glucose Monitoring Devices is forecast to a readjusted size of US$ 5872.7 million by 2030 with a CAGR of 3.8% during review period.
The research report highlights the growth potential of the global Continuous Glucose Monitoring Devices market. Continuous Glucose Monitoring Devices are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Continuous Glucose Monitoring Devices. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Continuous Glucose Monitoring Devices market.
A continuous glucose monitoring (CGM) system may help in these cases. The system consists of a small disposable sensor inserted into the skin, a transmitter connected to the sensor by a sensor mount wirelessly transmits results to a receiver and displays results.
Global Continuous Glucose Monitoring Systems key players include Dexcom, Abbott Laboratories, Medtronic, etc. Global top three manufacturers hold a share about 95%.
North America is the largest market, with a share about 65%, followed by Europe and Asia-Pacific, both have a share about 30 percent.
In terms of product, Wearable is the largest segment, with a share about 99%. And in terms of application, the largest application is Adult, followed by Elderly.
Key Features:
The report on Continuous Glucose Monitoring Devices market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Continuous Glucose Monitoring Devices market. It may include historical data, market segmentation by Type (e.g., Sensors, Transmitters & Receivers), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Continuous Glucose Monitoring Devices market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Continuous Glucose Monitoring Devices market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Continuous Glucose Monitoring Devices industry. This include advancements in Continuous Glucose Monitoring Devices technology, Continuous Glucose Monitoring Devices new entrants, Continuous Glucose Monitoring Devices new investment, and other innovations that are shaping the future of Continuous Glucose Monitoring Devices.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Continuous Glucose Monitoring Devices market. It includes factors influencing customer ' purchasing decisions, preferences for Continuous Glucose Monitoring Devices product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Continuous Glucose Monitoring Devices market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Continuous Glucose Monitoring Devices market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Continuous Glucose Monitoring Devices market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Continuous Glucose Monitoring Devices industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Continuous Glucose Monitoring Devices market.
Market Segmentation:
Continuous Glucose Monitoring Devices market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Sensors
Transmitters & Receivers
Insulin Pumps
Segmentation by application
Diabetic Patients
Healthy Individuals
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Echo Therapeutics, Inc.
Dexcom, Inc.
GlySens Incorporated
Medtronic plc
Senseonics Holdings, Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AgaMatrix, Inc.
Glucovation
GlySure
Arkray USA, Inc.
OrSense
Please note: The report will take approximately 2 business days to prepare and deliver.